Insider Transactions in Q2 2024 at Fulgent Genetics, Inc. (FLGT)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 01
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
982
-0.05%
|
$19,640
$20.65 P/Share
|
Jun 01
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,553
-0.36%
|
$31,060
$20.65 P/Share
|
Jun 01
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,479
-0.21%
|
$29,580
$20.65 P/Share
|
May 23
2024
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-0.3%
|
$44,331
$21.14 P/Share
|
May 23
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-0.31%
|
$14,049
$21.14 P/Share
|
May 23
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-0.04%
|
$7,602
$21.14 P/Share
|
May 23
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
653
-0.18%
|
$13,713
$21.14 P/Share
|
May 16
2024
|
Regina E Groves |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+33.33%
|
-
|
May 16
2024
|
Michael Nohaile |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+35.51%
|
-
|
May 16
2024
|
Linda Marsh |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+30.01%
|
-
|
May 03
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-0.64%
|
$29,652
$21.5 P/Share
|
May 03
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,719
-1.85%
|
$141,099
$21.5 P/Share
|
May 01
2024
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,337
-0.19%
|
$26,740
$20.7 P/Share
|
Apr 30
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-0.01%
|
$1,580
$20.35 P/Share
|
Apr 26
2024
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,154
-0.12%
|
$23,080
$20.1 P/Share
|
Apr 26
2024
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,738
-1.23%
|
$54,760
$20.1 P/Share
|
Apr 26
2024
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,344
-1.18%
|
$86,880
$20.1 P/Share
|